Sally Shorthose

Sep 11, 2024 | lexology.com | Sally Shorthose |Sophie Vo

This article is part of our series covering the proposed reforms to the EU pharmaceutical legislation. To view the entire series, click here. As covered in our article from last year, as part of the EU Pharmaceutical Reform, proposals were made to revise marketing authorisation (“MA”) procedures in the EU.

Oct 19, 2023 | managingip.com | Sally Shorthose

Brexit has had significant implications for research, science, and innovation. The deviation in the regulatory environment, reduced mobility of workers and access to research funding, and the way in which science and industry collaborate have each had their impact on research and innovation.